3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Active not recruiting
1
Sponsor Class
INDUSTRY
2
Study Type
Observational
2
Interventional
2
Sponsor
Cancer Type
Classical hematology
2
Conditions
Venous Thromboembolism
2
Neoplasms
2
Pulmonary Embolism
1
Myeloproliferative Disorders
1
Embolism
1
Interventions
Rivaroxaban
5
apixaban
4
Heparin, Low-Molecular-Weight
2
Dabigatran
2
ribociclib
1
palbociclib
1
edoxaban
1
calcium heparin
1
abemaciclib
1
Tinzaparin
1
Surveys and Questionnaires
1
Observation
1
Nadroparin
1
Mass Screening
1
Heparin
1
Fondaparinux
1
Enoxaparin
1
Data Collection
1
Dalteparin
1
Anticoagulants
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Observational
×
Venous Thromboembolism
×
Dabigatran
×
Clear all
NCT04618913
2026-05-26
VICTORIE
Pfizer
Active not recruiting
1 enrolled
NCT03965741
2021-11-30
PRACTISE
Bayer
Completed
97,765 enrolled